Nurse Practitioner · Las Vegas, NV
NPI
1750532131
Since 2008
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2000 Wellness Way
Las Vegas, NV, 89106
Phone (702) 384-5101
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
885 services
Medicare patients, 2024
199
Average age 72
Drug cost, 2024
$2.3M
2,896 prescriptions
Company payments, 2025
$4,758
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vivencio C Navarro was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 123 times for 106 patients. In total Vivencio C Navarro billed 885 services in 17 codes, and Medicare paid $33K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 123 | 106 | $10.39 | $1,278 |
| 99213 Office E&M - Established | Office | 112 | 86 | $48.41 | $5,422 |
| 99457 E&M - Miscellaneous | Office | 110 | 18 | $31.90 | $3,509 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 107 | 19 | $30.61 | $3,275 |
| 99458 E&M - Miscellaneous | Office | 88 | 15 | $25.59 | $2,252 |
| 99214 Office E&M - Established | Office | 86 | 68 | $71.81 | $6,176 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 80 | 19 | $39.68 | $3,174 |
| 99454 E&M - Miscellaneous | Office | 71 | 16 | $30.95 | $2,198 |
| 99212 Office E&M - Established | Office | 32 | 27 | $36.29 | $1,161 |
| 99203 Office E&M - New | Office | 29 | 29 | $65.57 | $1,902 |
| 99204 Office E&M - New | Office | 14 | 14 | $102.50 | $1,435 |
By year: 2022 $21K for 350 services; 2023 $22K for 395 services; 2024 $33K for 885 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vivencio C Navarro prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 464 prescriptions and refills. In total Vivencio C Navarro wrote 2,896 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 464 | 937 | 160 | $597K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 390 | 839 | 146 | $522K |
| Montelukast Sodium Generic | 359 | 971 | 133 | $3,322 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 311 | 367 | 111 | $10K |
| Fluticasone Propionate Generic | 179 | 288 | 81 | $2,133 |
| Azelastine Hcl Generic | 153 | 270 | 73 | $3,766 |
| Breo Ellipta Fluticasone/Vilanterol | 153 | 335 | 58 | $131K |
| Symbicort Budesonide/Formoterol Fumarate | 138 | 270 | 58 | $62K |
| Arnuity Ellipta Fluticasone Furoate | 120 | 238 | 42 | $48K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 110 | 273 | 42 | $129K |
| Prednisone Generic | 75 | 79 | 61 | $152 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 56 | 122 | 19 | $55K |
| Ventolin Hfa Albuterol Sulfate | 53 | 63 | 23 | $4,471 |
| Spiriva Respimat Tiotropium Bromide | 48 | 95 | 16 | $49K |
| Ofev Nintedanib Esylate | 18 | 18 | Under 11 | $245K |
Brand drugs: 1,832 claims; generic drugs: 1,064 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vivencio C Navarro $4,758 ($4,758 in general payments such as food, travel and fees) from 16 companies. The largest payer was Genzyme Corporation with $1,165.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 8 | $1,165 |
| AstraZeneca Pharmaceuticals LP AZN | 38 | $1,164 |
| Verona Pharma, Inc. VRNA | 17 | $938 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $357 |
| GlaxoSmithKline, LLC. GSK | 13 | $232 |
| Electromed, Inc. ELMD | 14 | $230 |
| Viatris Specialty LLC | 8 | $180 |
| Mylan Inc. | 1 | $127 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $119 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $69.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.